Cargando…
Outcomes and potential surrogate markers for future clinical trials of non‐alcoholic steatohepatitis cirrhosis
Non‐alcoholic steatohepatitis has emerged as a major public health problem, and the burden of non‐alcoholic steatohepatitis cirrhosis is projected to increase by 64%‐156% by 2030. The threat is aggravated by the fact that are currently no approved drugs for the treatment of non‐alcoholic steatohepat...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
John Wiley and Sons Inc.
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8457215/ https://www.ncbi.nlm.nih.gov/pubmed/34242466 http://dx.doi.org/10.1111/liv.15013 |